Heron Therapeutics Inc vs H World Group Limited American Depositary Shares — how do they compare? Heron Therapeutics Inc trades at $0.37 (market cap $68.01M), while H World Group Limited American Depositary Shares trades at $43.58 (market cap $13.25B). The key difference: H World Group Limited American Depositary Shares is far larger — about 194.8× Heron Therapeutics Inc's market cap, and H World Group Limited American Depositary Shares pays a 5.08% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Heron Therapeutics Inc for 35 Days and H World Group Limited American Depositary Shares for 0 Days on average.
| HRTX | HTHT | |
|---|---|---|
Market Cap | $68.01M | $13.25B |
Volume | 1,891,941 | 1,177,261 |
Sector | Health | Consumer Cyclical |
52-Week High | $1.49 | $56.06 |
52-Week Low | $0.27 | $36.99 |
Typical Hold Time | 35 Days | 0 Days |
Enterprise Value | $174.75M | $16.03B |
Dividend Yield | — | 5.08% |
Signals from Pluang's Aura AI — not financial advice
Heron Therapeutics (HRTX) is trading at $0.39, up 17.58% today, with a bullish technical outlook from moving averages but mixed signals from oscillators. The company maintains strong gross margins of 70.07% but continues to report net losses, with Q2 2026 missing both EPS and revenue expectations. Analyst sentiment remains overwhelmingly positive with 89% buy ratings despite recent earnings disappointments and negative profitability metrics.
While analyst consensus is strongly bullish, HRTX faces significant fundamental challenges including consistent net losses, negative ROE of -78.72%, and cash flow concerns. The stock's current momentum appears driven by technical factors rather than improving fundamentals, creating a high-risk investment profile that requires careful monitoring of upcoming Q3 earnings and revenue stabilization efforts.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →H World Group operates hotels through leased and owned, managed franchise, and franchise models. Its brands include HanTing, JI Hotel, Orange Hotel, and Steigenberger Hotels & Resorts.
Read more on HTHT →